Arrayit CNBC

News & Events - Press Release

ArrayIt® Featured on CNBC’s Business Oddysey Segment

Sunnyvale, CA, July 24, 2004 – On July 24th, TeleChem International, Inc. announced that it has been featured on CNBC in the Business Oddysey Segment.

Click Here to Watch ArrayIt® on CNBC’s Business Oddysey Segment.

About TeleChem International, Inc.
TeleChem International is a privately owned high-tech company located in the heart of California’s Silicon Valley. Our products and services are provided by three corporate divisions: ArrayIt® Life Sciences Division, Chemicals Division, and a Diagnostics Division. The ArrayIt® Life Sciences Division offers a complete microarray technology platform that empowers >10,000 laboratories to use microarrays for human genome exploration, basic research, drug discovery, and myriad life sciences applications. Nearly every major research institution uses our patented microarray manufacturing technology (U.S. 6,101,946) and supporting products and services. The Chemicals Division provides import and export services and government contract manufacturing in the area of industrial chemicals for plastics, fire control, water treatment, agriculture, industrial and institutional compounding, and green energy. The Diagnostics Division holds key patents in the United States (6,913,879), Singapore (94899), New Zealand (523560), and other countries for its revolutionary “multi-patient” genotyping technology, which allows as many as 100,000 patients to be tested on a single microarray. Arrayit Diagnostics enables genotyping and disease diagnostics by providing testing kits, services, and technology transfer opportunities for disease screening and testing organizations.

Media Contact
Paul Haje
Director of Public Relations
408-744-1331
Email: paul@arrayit.com